183 related articles for article (PubMed ID: 22933708)
1. Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth.
Bansal R; Tomar T; Ostman A; Poelstra K; Prakash J
Mol Cancer Ther; 2012 Nov; 11(11):2419-28. PubMed ID: 22933708
[TBL] [Abstract][Full Text] [Related]
2. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier.
Prakash J; de Jong E; Post E; Gouw AS; Beljaars L; Poelstra K
J Control Release; 2010 Jul; 145(2):91-101. PubMed ID: 20362019
[TBL] [Abstract][Full Text] [Related]
4. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Pietras K; Pahler J; Bergers G; Hanahan D
PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
[TBL] [Abstract][Full Text] [Related]
5. The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue.
Beljaars L; Weert B; Geerts A; Meijer DK; Poelstra K
Biochem Pharmacol; 2003 Oct; 66(7):1307-17. PubMed ID: 14505810
[TBL] [Abstract][Full Text] [Related]
6. Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.
Goto H; Nishioka Y
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286323
[TBL] [Abstract][Full Text] [Related]
7. IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4.
Deng J; Liu X; Rong L; Ni C; Li X; Yang W; Lu Y; Yan X; Qin C; Zhang L; Qin Z
J Pathol; 2014 Jun; 233(2):170-82. PubMed ID: 24615277
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo.
Bansal R; Prakash J; De Ruiter M; Poelstra K
J Control Release; 2014 Apr; 179():18-24. PubMed ID: 24491909
[TBL] [Abstract][Full Text] [Related]
9. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
10. Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo.
Bansal R; Prakash J; De Ruiter M; Poelstra K
PLoS One; 2014; 9(2):e89878. PubMed ID: 24587093
[TBL] [Abstract][Full Text] [Related]
11. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
Zeine R; Salwen HR; Peddinti R; Tian Y; Guerrero L; Yang Q; Chlenski A; Cohn SL
Mod Pathol; 2009 Jul; 22(7):950-8. PubMed ID: 19407854
[TBL] [Abstract][Full Text] [Related]
12. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of stromal fibroblasts to IFN-gamma blocks tumor growth via angiostasis.
Lu Y; Yang W; Qin C; Zhang L; Deng J; Liu S; Qin Z
J Immunol; 2009 Nov; 183(10):6413-21. PubMed ID: 19841170
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon gamma on native human acute myelogenous leukaemia cells.
Ersvaer E; Skavland J; Ulvestad E; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jan; 56(1):13-24. PubMed ID: 16612597
[TBL] [Abstract][Full Text] [Related]
15. Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth.
Shen J; Li ZJ; Li LF; Lu L; Xiao ZG; Wu WK; Zhang L; Li MX; Hu W; Chan KM; Cho CH
J Transl Med; 2016 Jun; 14(1):187. PubMed ID: 27342639
[TBL] [Abstract][Full Text] [Related]
16. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer.
Laing N; McDermott B; Wen S; Yang D; Lawson D; Collins M; Reimer C; Hall PA; Andersén H; Snaith M; Wang X; Bedian V; Cao ZA; Blakey D
Mol Pharmacol; 2013 Jun; 83(6):1247-56. PubMed ID: 23558446
[TBL] [Abstract][Full Text] [Related]
18. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.
Guo X; Oshima H; Kitmura T; Taketo MM; Oshima M
J Biol Chem; 2008 Jul; 283(28):19864-71. PubMed ID: 18495668
[TBL] [Abstract][Full Text] [Related]
19. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
[TBL] [Abstract][Full Text] [Related]
20. Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.
Kammertoens T; Friese C; Arina A; Idel C; Briesemeister D; Rothe M; Ivanov A; Szymborska A; Patone G; Kunz S; Sommermeyer D; Engels B; Leisegang M; Textor A; Fehling HJ; Fruttiger M; Lohoff M; Herrmann A; Yu H; Weichselbaum R; Uckert W; Hübner N; Gerhardt H; Beule D; Schreiber H; Blankenstein T
Nature; 2017 May; 545(7652):98-102. PubMed ID: 28445461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
